NPPB and Ventricular arrhythmia: NT‐proBNP concentrations are associated with the risk of incident ventricular arrhythmias in patients treated with implantable cardioverter defibrillator (ICD), with a stronger association among patients treated with ICD for secondary versus primary prevention.